The Next Generation of PBMs: New Technology, Simpler Business Model and More Transparency

August 10, 2020

Next generation PBMs like Flipt and RxSense are challenging the "old guard" PBMs that control three-quarters of the market.

FDA Updates: Assays Used in Cancer Care Get Green Light

August 09, 2020

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

What Are Health Plans Doing With Their Q2 Money?

August 09, 2020

In this part two of two video series Adam Block discusses his recent article, “Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates.”

ViiV Healthcare Receives FDA Approval for Drug to Treat Adults with HIV-1

August 08, 2020

Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.